Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/1314 : 16Business WireAlmirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio
2024/05/1314 : 15Business WireThe Eurofins Network Expands Battery Testing Services, Supporting Client Acceleration of Battery InnovationNYSE:ERFEnerplus Corporation
2024/05/1314 : 05Alliance NewsAlliance NewsQatarEnergy acquires stake in two Exxon-operated Egypt offshore blocksLSE:0R1MExxon Mobil Corp
2024/05/1314 : 03CointelegraphIt’s ‘clear’ the US government is going after Tether: Ripple CEOCOIN:XRPUSDRipple
2024/05/1314 : 03Alliance NewsAlliance NewsMicrosoft, Amazon to invest billions in French techLSE:0R1OAmazon.com Inc
2024/05/1314 : 03Alliance NewsAlliance NewsMicrosoft, Amazon to invest billions in French techLSE:0QYPMicrosoft Corp
2024/05/1314 : 01GlobeNewswire Inc.Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminiumTG:NHYLucapa Diamond Company Ltd
2024/05/1314 : 01GlobeNewswire Inc.Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminiumTG:A2R0MANorsk Hydro ASA
2024/05/1314 : 00GlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024EU:CRBNCorbion N.V.
2024/05/1314 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaireBIT:1SANSanofi
2024/05/1314 : 00GlobeNewswire Inc.Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026TG:AFRAir France KLM
2024/05/1314 : 00GlobeNewswire Inc.Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026LSE:AIRFAir France-Klm
2024/05/1314 : 00GlobeNewswire Inc.Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyBIT:SANFSanofi
2024/05/1314 : 00GlobeNewswire Inc.Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)NASDAQ:SNYSanofi
2024/05/1314 : 00GlobeNewswire Inc.Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)NASDAQ:REGNRegeneron Pharmaceuticals Inc
2024/05/1314 : 00GlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineTG:AYJValneva SE
2024/05/1314 : 00GlobeNewswire Inc.Norsk Hydro: Changes in Hydro’s Executive Leadership TeamTG:A2R0MANorsk Hydro ASA
2024/05/1314 : 00GlobeNewswire Inc.Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunyaTG:AYJValneva SE
2024/05/1314 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaireTG:SNWSanofi
2024/05/1314 : 00GlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineEU:VLAValneva SE
2024/05/1314 : 00GlobeNewswire Inc.Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunyaEU:VLAValneva SE
2024/05/1314 : 00GlobeNewswire Inc.Norsk Hydro: Changes in Hydro’s Executive Leadership TeamTG:NHYLucapa Diamond Company Ltd
2024/05/1314 : 00GlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineLSE:0OB3Valneva Se
2024/05/1314 : 00GlobeNewswire Inc.Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya VaccineEU:VLAValneva SE
2024/05/1314 : 00GlobeNewswire Inc.Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)EU:SANSanofi
2024/05/1314 : 00GlobeNewswire Inc.Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024TG:CSUACorbion N.V.
2024/05/1314 : 00GlobeNewswire Inc.Start of Day Message
2024/05/1314 : 00GlobeNewswire Inc.Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunyaLSE:0OB3Valneva Se
2024/05/1314 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaireBIT:SANFSanofi
2024/05/1314 : 00GlobeNewswire Inc.Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyTG:SNWSanofi

最近閲覧した銘柄

Delayed Upgrade Clock